1. In this phase 2 randomized controlled trial, weekly subcutaneous mezagitimab was well-tolerated and associated with symptomatic improvement among patients...

1. In this cluster-randomized trial (IMPACTS-BP), patients with longstanding uncontrolled hypertension who underwent multimodal intervention had significantly greater decreases in...

1. This randomized controlled trial involving subjects with asymptomatic, very severe aortic stenosis demonstrated that over a ten-year period, early...

1. In this phase 1/2a trial involving patients with Dravet syndrome who received intrathecal zorevunersen, treatment-related adverse events occurred in...

1. In this phase 3 trial involving patients with type 1 diabetes and chronic kidney disease, finerenone was associated with...

1. In this phase 3, randomized, placebo-controlled trial, an antiviral medication approved for treating smallpox (tecovirimat) did not accelerate clinical...

1. In this phase 1-2 single-group trial, the p53 reactivator rezatapopt was well-tolerated in adults with solid tumors harboring the...

1. In this phase 1-2 randomized controlled trial involving adults with myotonic dystrophy type 1, del-desiran was well-tolerated in most...

1. In this prospective cohort study, CD19-directed chimeric antigen receptor (CAR) T-cell therapy was found to elicit a complete response...

1. In this randomized controlled trial of adults with central retinal artery occlusion, tenecteplase administration shortly after symptom onset did...